- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.81 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.4: 9 residues within 4Å:- Chain A: S.577, S.580, A.581, N.584, Q.686
- Chain B: H.58, E.222, Y.223, R.300
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.222, B:E.222, B:R.300, B:R.300
NAG-NAG-BMA-MAN.16: 9 residues within 4Å:- Chain A: H.58, E.222, Y.223, R.300
- Chain B: S.577, S.580, A.581, N.584, Q.686
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.222, A:E.222, A:R.300, A:R.300
- 4 x ZN: ZINC ION(Non-covalent)
ZN.5: 5 residues within 4Å:- Chain A: D.333, E.371, H.499
- Ligands: ZN.6, 5PU.11
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:D.333, A:E.371, A:E.371, A:H.499
ZN.6: 7 residues within 4Å:- Chain A: H.323, D.333, E.370, E.371, D.399
- Ligands: ZN.5, 5PU.11
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.323, A:D.333, A:D.399, A:D.399, H2O.9
ZN.17: 5 residues within 4Å:- Chain B: D.333, E.371, H.499
- Ligands: ZN.18, 5PU.23
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:D.333, B:E.371, B:E.371, B:H.499
ZN.18: 7 residues within 4Å:- Chain B: H.323, D.333, E.370, E.371, D.399
- Ligands: ZN.17, 5PU.23
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.323, B:D.333, B:D.399, B:D.399, H2O.27
- 2 x CA: CALCIUM ION(Non-covalent)
CA.7: 4 residues within 4Å:- Chain A: T.215, Y.218, E.379, E.382
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:T.215, A:Y.218, A:E.379, A:E.379, A:E.382
CA.19: 4 residues within 4Å:- Chain B: T.215, Y.218, E.379, E.382
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:T.215, B:Y.218, B:E.379, B:E.379, B:E.382
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.9: 4 residues within 4Å:- Chain A: N.67, T.69, H.70, T.295
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.67, A:T.69, A:H.70
NAG.10: 4 residues within 4Å:- Chain A: W.192, N.405, F.511, Y.512
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:W.192, A:Y.512
- Hydrogen bonds: A:W.192, A:F.511
- Water bridges: A:N.405, A:Y.518
NAG.21: 4 residues within 4Å:- Chain B: N.67, T.69, H.70, T.295
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.67, B:T.69, B:H.70
NAG.22: 4 residues within 4Å:- Chain B: W.192, N.405, F.511, Y.512
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:W.192, B:Y.512
- Hydrogen bonds: B:W.192, B:F.511
- Water bridges: B:N.405, B:Y.518
- 2 x 5PU: 4-[(2~{R})-2-carboxy-5-(oxidanylamino)-5-oxidanylidene-pentyl]benzoic acid(Non-covalent)
5PU.11: 16 residues within 4Å:- Chain A: Y.180, H.323, D.333, E.370, E.371, D.399, G.464, N.465, R.480, G.494, Y.495, Y.498, H.499
- Ligands: ZN.5, ZN.6, ACT.12
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:E.370, A:N.465, A:G.494, A:Y.495, A:Y.495
- Water bridges: A:Q.200
- Salt bridges: A:R.480
- pi-Stacking: A:Y.498
5PU.23: 16 residues within 4Å:- Chain B: Y.180, H.323, D.333, E.370, E.371, D.399, G.464, N.465, R.480, G.494, Y.495, Y.498, H.499
- Ligands: ZN.17, ZN.18, ACT.24
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:E.370, B:N.465, B:G.494, B:Y.495, B:Y.495
- Water bridges: B:Q.200
- Salt bridges: B:R.480
- pi-Stacking: B:Y.498
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.12: 7 residues within 4Å:- Chain A: F.155, R.156, E.371, G.464, Y.498, H.499
- Ligands: 5PU.11
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.155
- Hydrogen bonds: A:N.203, A:Y.498
- Water bridges: A:R.156, A:R.156, A:N.203, A:E.370, A:E.371
- Salt bridges: A:R.156, A:H.499
ACT.24: 7 residues within 4Å:- Chain B: F.155, R.156, E.371, G.464, Y.498, H.499
- Ligands: 5PU.23
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:F.155
- Hydrogen bonds: B:N.203, B:Y.498
- Water bridges: B:R.156, B:R.156, B:N.203, B:E.370, B:E.371
- Salt bridges: B:R.156, B:H.499
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Novakova, Z. et al., Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity. J.Med.Chem. (2016)
- Release Date
- 2016-04-27
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.81 Å
- Oligo State
- homo-dimer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x 5PU: 4-[(2~{R})-2-carboxy-5-(oxidanylamino)-5-oxidanylidene-pentyl]benzoic acid(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Novakova, Z. et al., Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity. J.Med.Chem. (2016)
- Release Date
- 2016-04-27
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A